Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Change in Acquisitions & Divestments (2022 - 2023)

Historic Change in Acquisitions & Divestments for HCW Biologics (HCWB) over the last 2 years, with Q3 2023 value amounting to $10.0 million.

  • HCW Biologics' Change in Acquisitions & Divestments fell 4111.99% to $10.0 million in Q3 2023 from the same period last year, while for Dec 2024 it was $10.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.0 million for FY2023, which is 5997.36% down from last year.
  • Per HCW Biologics' latest filing, its Change in Acquisitions & Divestments stood at $10.0 million for Q3 2023, which was down 4111.99% from $17.0 million recorded in Q3 2022.
  • In the past 5 years, HCW Biologics' Change in Acquisitions & Divestments ranged from a high of $17.0 million in Q3 2022 and a low of $8.0 million during Q1 2022